143 related articles for article (PubMed ID: 26810610)
1. Tigecycline as last resort in severe refractory Clostridium difficile infection: a case report.
Knafl D; Winhofer Y; Lötsch F; Weisshaar S; Steininger C; Burgmann H; Thalhammer F
J Hosp Infect; 2016 Mar; 92(3):296-8. PubMed ID: 26810610
[No Abstract] [Full Text] [Related]
2. Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.
Di Bella S; Nisii C; Petrosillo N
Int J Antimicrob Agents; 2015 Jul; 46(1):8-12. PubMed ID: 25982915
[TBL] [Abstract][Full Text] [Related]
3. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
El-Herte RI; Baban TA; Kanj SS
Scand J Infect Dis; 2012 Mar; 44(3):228-30. PubMed ID: 22077098
[TBL] [Abstract][Full Text] [Related]
4. Tigecycline exhibits inhibitory activity against Clostridium difficile in the intestinal tract of hospitalised patients.
Kundrapu S; Hurless K; Sunkesula VC; Tomas M; Donskey CJ
Int J Antimicrob Agents; 2015 Apr; 45(4):424-6. PubMed ID: 25623897
[TBL] [Abstract][Full Text] [Related]
5. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
[TBL] [Abstract][Full Text] [Related]
6. Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole.
Lu CL; Liu CY; Liao CH; Huang YT; Wang HP; Hsueh PR
Int J Antimicrob Agents; 2010 Mar; 35(3):311-2. PubMed ID: 20045292
[No Abstract] [Full Text] [Related]
7. Tigecycline for severe Clostridium difficile infection.
Thomas A; Khan F; Uddin N; Wallace MR
Int J Infect Dis; 2014 Sep; 26():171-2. PubMed ID: 25064460
[TBL] [Abstract][Full Text] [Related]
8. Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients.
Metan G; Türe Z; Kaynar L; Berk E; Gürsoy Ş; Alp E; Kılıç H; Çetin M
J Chemother; 2015; 27(6):354-7. PubMed ID: 25407220
[No Abstract] [Full Text] [Related]
9. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.
Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I
J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480
[TBL] [Abstract][Full Text] [Related]
10. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
Bishop EJ; Tiruvoipati R; Metcalfe J; Marshall C; Botha J; Kelley PG
Intern Med J; 2018 Jun; 48(6):651-660. PubMed ID: 29363242
[TBL] [Abstract][Full Text] [Related]
11. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study.
Garey KW; Jiang ZD; Bellard A; Dupont HL
J Clin Gastroenterol; 2009 Jan; 43(1):91-3. PubMed ID: 18385603
[No Abstract] [Full Text] [Related]
12. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
Huggan PJ; Murdoch DR
Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
[No Abstract] [Full Text] [Related]
13. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
[TBL] [Abstract][Full Text] [Related]
14. Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection.
Herpers BL; Vlaminckx B; Burkhardt O; Blom H; Biemond-Moeniralam HS; Hornef M; Welte T; Kuijper EJ
Clin Infect Dis; 2009 Jun; 48(12):1732-5. PubMed ID: 19435431
[TBL] [Abstract][Full Text] [Related]
15. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
Lam SW; Bass SN; Neuner EA; Bauer SR
Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile-associated disease treatment response depends on definition of cure.
Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
[No Abstract] [Full Text] [Related]
17. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Bishara J; Wattad M; Paul M
Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
[No Abstract] [Full Text] [Related]
18. Clostridium difficile infection and proton pump inhibitors.
Pohl JF
Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
[TBL] [Abstract][Full Text] [Related]
19. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Tart SB
J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
[TBL] [Abstract][Full Text] [Related]
20. Management of Clostridium difficile infection: survey of practices and compliance with national guidelines among primary care physicians.
Byker GL; Dinh MT; Gunaratnam NT; Robinson EA; Shehab TM; Malani AN
Infect Control Hosp Epidemiol; 2009 Apr; 30(4):397-9. PubMed ID: 19239379
[No Abstract] [Full Text] [Related]
[Next] [New Search]
